Exact Mass: 476.02991560000004

Exact Mass Matches: 476.02991560000004

Found 51 metabolites which its exact mass value is equals to given mass value 476.02991560000004, within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error 0.01 dalton.

Cefazolin sodium

Cephazolin sodium

C14H13N8NaO4S3 (476.01195780000006)


D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D002511 - Cephalosporins D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D047090 - beta-Lactams D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D007769 - Lactams C254 - Anti-Infective Agent > C258 - Antibiotic > C260 - Beta-Lactam Antibiotic

   

Ellagic acid acetyl-xyloside

(3R,4R,5R,6S)-4,5-dihydroxy-6-({7,13,14-trihydroxy-3,10-dioxo-2,9-dioxatetracyclo[6.6.2.0⁴,¹⁶.0¹¹,¹⁵]hexadeca-1(15),4(16),5,7,11,13-hexaen-6-yl}oxy)oxan-3-yl acetate

C21H16O13 (476.0590886)


Ellagic acid acetyl-xyloside is a member of the class of compounds known as hydrolyzable tannins. Hydrolyzable tannins are tannins with a structure characterized by either of the following models. In model 1, the structure contains galloyl units (in some cases, shikimic acid units) are linked to diverse polyol carbohydrate-, catechin-, or triterpenoid units. In model 2, contains at least two galloyl units C-C coupled to each other, and do not contain a glycosidically linked catechin unit. Ellagic acid acetyl-xyloside is slightly soluble (in water) and a very weakly acidic compound (based on its pKa). Ellagic acid acetyl-xyloside can be found in red raspberry, which makes ellagic acid acetyl-xyloside a potential biomarker for the consumption of this food product.

   

Ellagic acid acetyl-arabinoside

(3S,4R,5R,6S)-4,5-dihydroxy-6-({7,13,14-trihydroxy-3,10-dioxo-2,9-dioxatetracyclo[6.6.2.0⁴,¹⁶.0¹¹,¹⁵]hexadeca-1(15),4(16),5,7,11,13-hexaen-6-yl}oxy)oxan-3-yl acetate

C21H16O13 (476.0590886)


Ellagic acid acetyl-arabinoside is a member of the class of compounds known as hydrolyzable tannins. Hydrolyzable tannins are tannins with a structure characterized by either of the following models. In model 1, the structure contains galloyl units (in some cases, shikimic acid units) are linked to diverse polyol carbohydrate-, catechin-, or triterpenoid units. In model 2, contains at least two galloyl units C-C coupled to each other, and do not contain a glycosidically linked catechin unit. Ellagic acid acetyl-arabinoside is slightly soluble (in water) and a very weakly acidic compound (based on its pKa). Ellagic acid acetyl-arabinoside can be found in red raspberry, which makes ellagic acid acetyl-arabinoside a potential biomarker for the consumption of this food product.

   
   

2,6-Bis(2,2,2-trifluoroethoxy)-3-{[3-(trifluoromethyl)-2-pyridyl]thio}benzonitrile

2,6-Bis(2,2,2-trifluoroethoxy)-3-{[3-(trifluoromethyl)-2-pyridyl]thio}benzonitrile

C17H9F9N2O2S (476.02410019999996)


   

PRZ_M477

PRZ_M477

C18H22Cl2N4O5S (476.0687902)


CONFIDENCE Tentative identification only (Level 3); INTERNAL_ID 2017

   
   
   

(2R,3S,4R,5S,6S,7R)-2,3,5,6,7-pentachloropentadec-14-en-4-yl hydrogen sulfate

(2R,3S,4R,5S,6S,7R)-2,3,5,6,7-pentachloropentadec-14-en-4-yl hydrogen sulfate

C15H25Cl5O4S (475.9916120000001)


   

3,4-dioxoloellagic acid 4-glucoside|3,4-methylene-4-O-beta-D-glucopyranosylellagic acid|3,4-methylenedioxyellagic acid 4-O-beta-D-glucopyranoside|okicamelliaside

3,4-dioxoloellagic acid 4-glucoside|3,4-methylene-4-O-beta-D-glucopyranosylellagic acid|3,4-methylenedioxyellagic acid 4-O-beta-D-glucopyranoside|okicamelliaside

C21H16O13 (476.0590886)


   

Neoirienone|neoirieone

Neoirienone|neoirieone

C20H30Br2O3 (476.056155)


   
   
   

(4-Bromobutyl)(triphenyl)phosphonium bromide

(4-Bromobutyl)(triphenyl)phosphonium bromide

C22H23Br2P (475.99040080000003)


   

sodium,formaldehyde,2-hydroxybenzenesulfonate,4-(4-hydroxyphenyl)sulfonylphenol

sodium,formaldehyde,2-hydroxybenzenesulfonate,4-(4-hydroxyphenyl)sulfonylphenol

C19H17NaO9S2 (476.0211672)


   

1-[4-chloro-3-(trifluoromethyl)phenyl]-3-[4-[6-(1,2,4-oxadiazol-3-yl)pyrimidin-4-yl]oxyphenyl]urea

1-[4-chloro-3-(trifluoromethyl)phenyl]-3-[4-[6-(1,2,4-oxadiazol-3-yl)pyrimidin-4-yl]oxyphenyl]urea

C20H12ClF3N6O3 (476.06114679999996)


   
   

PH-797804

3-(3-Bromo-4-((2,4-difluorobenzyl)oxy)-6-methyl-2-oxopyridin-1(2H)-yl)-N,4-dimethylbenzamide

C22H19BrF2N2O3 (476.0547028000001)


   

(R,R)-1,2-Bis(Trifluoromethanesulfonamido)-1,2-Diphenylethane

(R,R)-1,2-Bis(Trifluoromethanesulfonamido)-1,2-Diphenylethane

C16H14F6N2O4S2 (476.02991560000004)


   

6,13-dibromo-9,10-dimethoxy-1a,2,3,4,4a,5-hexahydro-1H-indeno[2,1-d]fluorene

6,13-dibromo-9,10-dimethoxy-1a,2,3,4,4a,5-hexahydro-1H-indeno[2,1-d]fluorene

C22H22Br2O2 (475.99864319999995)


   
   

Sitaxentan sodium

Sitaxentan sodium

C18H14ClN2NaO6S2 (475.98794940000005)


Sitaxsentan sodium (IPI 1040 sodium; TBC11251 sodium) is an orally active, highly selective antagonist of endothelin A receptors.

   

[[[1-[5-[2-Chloro-4-(trifluoromethyl)phenoxy]-2-nitrophenyl]-2-methoxyethylidene]amino]oxy]acetic acid methyl ester

[[[1-[5-[2-Chloro-4-(trifluoromethyl)phenoxy]-2-nitrophenyl]-2-methoxyethylidene]amino]oxy]acetic acid methyl ester

C19H16ClF3N2O7 (476.0598092)


   

(Trimethylsilylmethyl)triphenylphosphonium iodide

(Trimethylsilylmethyl)triphenylphosphonium iodide

C22H26IPSi (476.0586076)


   

(3-BROMOBUTYL)TRIPHENYLPHONIUM BROMIDE

(3-BROMOBUTYL)TRIPHENYLPHONIUM BROMIDE

C22H23Br2P (475.99040080000003)


   

1H,1H,2H,3H-PERFLUOROUNDEC-2-EN-1-OL

1H,1H,2H,3H-PERFLUOROUNDEC-2-EN-1-OL

C11H5F17O (476.00689239999997)


   

N,N-((1S,2S)-1,2-DIPHENYLETHANE-1,2-DIYL)BIS(1,1,1-TRIFLUOROMETHANESULFONAMIDE)

N,N-((1S,2S)-1,2-DIPHENYLETHANE-1,2-DIYL)BIS(1,1,1-TRIFLUOROMETHANESULFONAMIDE)

C16H14F6N2O4S2 (476.02991560000004)


   

Arbidol

Arbidol

C22H25BrN2O3S (476.076916)


J - Antiinfectives for systemic use > J05 - Antivirals for systemic use > J05A - Direct acting antivirals COVID info from DrugBank, clinicaltrial, clinicaltrials, clinical trial, clinical trials C254 - Anti-Infective Agent > C281 - Antiviral Agent Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS

   

mercuric salicylate

mercuric salicylate

C14H10HgO6 (476.018368)


   

sodium,formaldehyde,4-hydroxybenzenesulfonic acid,4-(4-hydroxyphenyl)sulfonylphenolate

sodium,formaldehyde,4-hydroxybenzenesulfonic acid,4-(4-hydroxyphenyl)sulfonylphenolate

C19H17NaO9S2 (476.0211672)


   
   

Benzamide, N-(cyclopropylmethoxy)-3,4,5-trifluoro-2-((4-iodo-2-methylphenyl)amino)-

Benzamide, N-(cyclopropylmethoxy)-3,4,5-trifluoro-2-((4-iodo-2-methylphenyl)amino)-

C18H16F3IN2O2 (476.02085819999996)


   

2-[(chloroacetyl)(3-chloro-4-methoxyphenyl)amino]-N-(2-phenylethyl)-2-thien-2-ylacetamide

2-[(chloroacetyl)(3-chloro-4-methoxyphenyl)amino]-N-(2-phenylethyl)-2-thien-2-ylacetamide

C23H22Cl2N2O3S (476.07281220000004)


   

[10-(4-chlorophenyl)-2,6,8-trioxo-3,4a,5,5a,6,8,8a,9,9a,10-decahydro-5,9-methano[1,3]thiazolo[5,4:5,6]thiopyrano[2,3-f]isoindol-7(2H)-yl]acetic acid

[10-(4-chlorophenyl)-2,6,8-trioxo-3,4a,5,5a,6,8,8a,9,9a,10-decahydro-5,9-methano[1,3]thiazolo[5,4:5,6]thiopyrano[2,3-f]isoindol-7(2H)-yl]acetic acid

C21H17ClN2O5S2 (476.0267382)


   

2-({4-[(5-Chloro-1H-indol-2-YL)sulfonyl]piperazin-1-YL}carbonyl)thieno[3,2-B]pyridine 4-oxide

2-({4-[(5-Chloro-1H-indol-2-YL)sulfonyl]piperazin-1-YL}carbonyl)thieno[3,2-B]pyridine 4-oxide

C20H17ClN4O4S2 (476.0379712)


   

S-(2,4-dichloro-6-hydroxy-3-{2-[(1H-imidazole-1-carbonyl)(propyl)amino]ethoxy}phenyl)cysteine

S-(2,4-dichloro-6-hydroxy-3-{2-[(1H-imidazole-1-carbonyl)(propyl)amino]ethoxy}phenyl)cysteine

C18H22Cl2N4O5S (476.0687902)


   

(2S,3S,4S,5R,6S)-6-[4-(5,7-dihydroxy-3-oxido-4-oxochromen-2-yl)-2-hydroxyphenoxy]-3,4,5-trihydroxyoxane-2-carboxylate

(2S,3S,4S,5R,6S)-6-[4-(5,7-dihydroxy-3-oxido-4-oxochromen-2-yl)-2-hydroxyphenoxy]-3,4,5-trihydroxyoxane-2-carboxylate

C21H16O13-2 (476.0590886)


   

N-[2-[(5Z)-2,4-dioxo-5-(pyridin-3-ylmethylidene)-1,3-thiazolidin-3-yl]ethyl]-4-methylsulfonyl-3-nitrobenzamide

N-[2-[(5Z)-2,4-dioxo-5-(pyridin-3-ylmethylidene)-1,3-thiazolidin-3-yl]ethyl]-4-methylsulfonyl-3-nitrobenzamide

C19H16N4O7S2 (476.0460386)


   

2-[(2Z)-2-[[4-(4-chlorophenyl)-1,3-thiazol-2-yl]methylidene]-4-oxo-1,3-thiazolidin-3-yl]-N-(2-chloropyridin-3-yl)acetamide

2-[(2Z)-2-[[4-(4-chlorophenyl)-1,3-thiazol-2-yl]methylidene]-4-oxo-1,3-thiazolidin-3-yl]-N-(2-chloropyridin-3-yl)acetamide

C20H14Cl2N4O2S2 (475.99352039999997)


   

2-{[5-(4-bromophenyl)-4-imino-3-methyl-4,5-dihydro-1H-pyrazolo[3,4-d]pyrimidin-6-yl]thio}-N-(tetrahydrofuran-2-ylmethyl)acetamide

2-{[5-(4-bromophenyl)-4-imino-3-methyl-4,5-dihydro-1H-pyrazolo[3,4-d]pyrimidin-6-yl]thio}-N-(tetrahydrofuran-2-ylmethyl)acetamide

C19H21BrN6O2S (476.0629986)


   

(1r,4r,5s,6s,9r)-9-bromo-4-{[(1r,4r)-4-bromo-1-hydroxy-3,3-dimethylcyclohexyl]methyl}-6-methyl-11-oxatricyclo[4.3.2.0¹,⁵]undecan-10-one

(1r,4r,5s,6s,9r)-9-bromo-4-{[(1r,4r)-4-bromo-1-hydroxy-3,3-dimethylcyclohexyl]methyl}-6-methyl-11-oxatricyclo[4.3.2.0¹,⁵]undecan-10-one

C20H30Br2O3 (476.056155)


   

2',3-dihydroxy-7-methoxy-6'-methyl-3h-5',12',15'-trioxaspiro[naphtho[2,3-b]furan-2,14'-tetracyclo[8.5.0.0³,⁸.0¹¹,¹³]pentadecane]-1'(10'),2',6',8'-tetraene-4',5,8-trione

2',3-dihydroxy-7-methoxy-6'-methyl-3h-5',12',15'-trioxaspiro[naphtho[2,3-b]furan-2,14'-tetracyclo[8.5.0.0³,⁸.0¹¹,¹³]pentadecane]-1'(10'),2',6',8'-tetraene-4',5,8-trione

C25H16O10 (476.0743436)


   

[(2r,3s,4r,5s,6s,7r)-2,3,5,6,7-pentachloropentadec-14-en-4-yl]oxysulfonic acid

[(2r,3s,4r,5s,6s,7r)-2,3,5,6,7-pentachloropentadec-14-en-4-yl]oxysulfonic acid

C15H25Cl5O4S (475.9916120000001)


   

(2,3,5,6,7-pentachloropentadec-14-en-4-yl)oxysulfonic acid

(2,3,5,6,7-pentachloropentadec-14-en-4-yl)oxysulfonic acid

C15H25Cl5O4S (475.9916120000001)


   

8-bromo-10a-(bromomethyl)-5,6-dihydroxy-1-isopropyl-5,8a-dimethyl-1,4a,4b,6,7,8,9,10-octahydrophenanthren-4-one

8-bromo-10a-(bromomethyl)-5,6-dihydroxy-1-isopropyl-5,8a-dimethyl-1,4a,4b,6,7,8,9,10-octahydrophenanthren-4-one

C20H30Br2O3 (476.056155)


   

8-bromo-2,5,10-trihydroxy-2-isopropyl-3'-methoxy-3-methyl-3h-spiro[anthracene-1,2'-furan]-4,5'-dione

8-bromo-2,5,10-trihydroxy-2-isopropyl-3'-methoxy-3-methyl-3h-spiro[anthracene-1,2'-furan]-4,5'-dione

C22H21BrO7 (476.0470576)


   

(1r,4as,4bs,5s,6s,8s,8as,10as)-8-bromo-10a-(bromomethyl)-5,6-dihydroxy-1-isopropyl-5,8a-dimethyl-1,4a,4b,6,7,8,9,10-octahydrophenanthren-4-one

(1r,4as,4bs,5s,6s,8s,8as,10as)-8-bromo-10a-(bromomethyl)-5,6-dihydroxy-1-isopropyl-5,8a-dimethyl-1,4a,4b,6,7,8,9,10-octahydrophenanthren-4-one

C20H30Br2O3 (476.056155)


   

(1s,4s,5s,6r,9s)-9-bromo-4-{[(1s,4s)-4-bromo-1-hydroxy-3,3-dimethylcyclohexyl]methyl}-6-methyl-11-oxatricyclo[4.3.2.0¹,⁵]undecan-10-one

(1s,4s,5s,6r,9s)-9-bromo-4-{[(1s,4s)-4-bromo-1-hydroxy-3,3-dimethylcyclohexyl]methyl}-6-methyl-11-oxatricyclo[4.3.2.0¹,⁵]undecan-10-one

C20H30Br2O3 (476.056155)


   

(5s,6s)-9-bromo-4-[(4-bromo-1-hydroxy-3,3-dimethylcyclohexyl)methyl]-6-methyl-11-oxatricyclo[4.3.2.0¹,⁵]undecan-10-one

(5s,6s)-9-bromo-4-[(4-bromo-1-hydroxy-3,3-dimethylcyclohexyl)methyl]-6-methyl-11-oxatricyclo[4.3.2.0¹,⁵]undecan-10-one

C20H30Br2O3 (476.056155)


   

9-bromo-4-[(4-bromo-1-hydroxy-3,3-dimethylcyclohexyl)methyl]-6-methyl-11-oxatricyclo[4.3.2.0¹,⁵]undecan-10-one

9-bromo-4-[(4-bromo-1-hydroxy-3,3-dimethylcyclohexyl)methyl]-6-methyl-11-oxatricyclo[4.3.2.0¹,⁵]undecan-10-one

C20H30Br2O3 (476.056155)